Skip to main content

Table 6 Multivariable Cox regression model for detecting the independent effect of post-procedural diabetic control on major adverse cardiovascular events (MACE) at 12 months

From: Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting

 

Odds ratio

95% confidence interval

P value

At Baseline

Non-diabetics (n = 2181)

1*

–

–

Good-control diabetics 1 (n = 291)

1.54

0.74 to 3.19

0.250

Poor-control diabetics 2 (n = 412)

1.98

1.06 to 3.68

0.032

1-month landmark analysis

Non-diabetics (n = 2147)

1*

–

–

Good-control diabetics 1 (n = 295)

2.02

0.80 to 5.09

0.136

Poor-control diabetics 2 (n = 402)

3.25

1.57 to 6.71

0.001

6-month landmark analysis

Non-diabetics (n = 2133)

1*

–

–

Good-control diabetics 1 (n = 256)

1.40

0.60 to 7.90

0.236

Poor-control diabetics 2 (n = 430)

4.10

1.04 to 7.81

0.043

  1. *Reference group.
  2. 1 Diabetic patient with HbA1c ≤ 7%.
  3. 2 Diabetic patient with HbA1c > 7%.